You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華森製藥(002907.SZ):收到公司產品都樑軟膠囊和長鬆的藥品再註冊批件
格隆匯 06-17 16:36

格隆匯 6 月 17日丨華森製藥(002907.SZ)公佈,近日收到重慶市藥品監督管理局(以下簡稱“市藥監局”)核准簽發的公司產品都樑軟膠囊和長鬆(聚乙二醇4000散)的“藥品再註冊批件”。

再註冊批件主要信息

(一)都樑軟膠囊

藥品通用名稱:都樑軟膠囊

批件號:2020R000162

劑型:膠囊劑

規格:每粒裝0.54g

藥品分類:中藥

藥品標準:《中國藥典》2015年版一部

藥品有效期:24個月

藥品批准文號:國藥準字Z20055185

藥品批准文號有效期:2025-04-13

審批結論:經審查,本品符合《藥品註冊管理辦法》的有關規定,同意再註冊。

(二)長鬆(聚乙二醇4000散)

藥品通用名稱:聚乙二醇4000散

商品名:長鬆

英文名/拉丁名:Macrogol4000Powder

批件號:2020R000164

劑型:散劑

規格:10g

藥品分類:化學藥品

藥品標準:YBH06902018

藥品有效期:24個月

藥品批准文號:國藥準字H20050809

藥品批准文號有效期:2025-04-06

審批結論:經審查,本品符合《藥品註冊管理辦法》的有關規定,同意再註冊。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account